Abstract
Sir , The publication by Ott et al. (1) restates the important, and topical, use of microbes in treating disease, in this case lymphoid immunodeficiencies. However, not everyone agrees that recombinant bacteria should be used in humans, and one particular submission to this journal called for a ban of such uses, a viewpoint that we wish to now strongly challenge (2).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
